LETTERS IN DRUG DESIGN & DISCOVERY, vol.15, no.11, pp.1155-1162, 2018 (SCI-Expanded)
Background: A series of 2-substituted benzoxazoles and their possible metabolites, N-(2-hydroxy-4(or 5)-nitrophenyl)benzamides and phenylacetamides, which were previously synthesized by our group, were investigated for their inhibitory activities on both eukaryotic DNA topoisomerase I (Topo I) and II (Topo II).